Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Post by williecoyoteon Mar 19, 2019 6:04am
152 Views
Post# 29504368

news

news

March 19 (Reuters) - Cann Group Ltd:

* ENTERED INTO A NON-BINDING HEADS OF AGREEMENT TO PURCHASE A SITE LOCATED WITHIN MILDURA REGION TO CONSTRUCT A STATE-OF-ART GREENHOUSE

* NEW GREENHOUSE FACILITY EXPECTED TO BE FULLY COMMISSIONED IN Q3 2020 WITH ESTIMATED CONSTRUCTION COST OF ABOUT $130 MILLION

* ENTERED AGREEMENT WITH AURORA CANNABIS INC FOR OFFTAKE OF MEDICINAL CANNABIS PRODUCED BY CANN

* "REVENUE GUIDANCE REAFFIRMED OF $160M-$200M ONCE MILDURA FACILITY FULLY COMMISSIONED"

* TO PURCHASE SITE IN MILDURA RURAL CITY COUNCIL FOR $10.75 MILLION TO CONSTRUCT GREENHOUSE FOR PRODUCTION OF MEDICINAL CANNABIS Source text (https://bit.ly/2Y8pgar) Further company coverage:

 
Bullboard Posts